Metraipolis › archive › dc_b4cda017befe

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer — Europe PMC PMID:33945523

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33945523
DOI
10.1371/journal.pgen.1009553
License (as archived)
CC0-1.0
Archived
2026-11-04T13:17:48.640Z
SHA-256 of the archived text
8fd8250956e98952cf27819096b2220f89629e9a104a33184c1f74301ce29d63
Stable URL of this page
https://metraipolis.com/documento/dc_b4cda017befe

How to cite

CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer — Europe PMC PMID:33945523 — Europe PMC (en), https://europepmc.org/article/MED/33945523 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b4cda017befe (Metraipolis archive dc_b4cda017befe, sha256 8fd8250956e98952cf27819096b2220f89629e9a104a33184c1f74301ce29d63)
BibTeX
@misc{dcb4cda017befe,
  title = {CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer — Europe PMC PMID:33945523},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33945523},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b4cda017befe; sha256 8fd8250956e98952cf27819096b2220f89629e9a104a33184c1f74301ce29d63},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/33945523. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The CBFB gene is frequently mutated in several types of solid tumors. Emerging evidence suggests that CBFB is a tumor suppressor in breast cancer. However, our understanding of the tumor suppressive function of CBFB remains incomplete. Here, we analyze genetic interactions between mutations of CBFB and other highly mutated genes in human breast cancer datasets and find that CBFB and TP53 mutations are mutually exclusive, suggesting a functional association between CBFB and p53. Integrated genomic studies reveal that TAp73 is a common transcriptional target of CBFB and p53. CBFB cooperates with p53 to maintain TAp73 expression, as either CBFB or p53 loss leads to TAp73 depletion. TAp73 re-expression abrogates the tumorigenic effect of CBFB deletion. Although TAp73 loss alone is insufficient for tumorigenesis, it enhances the tumorigenic effect of NOTCH3 overexpression, a downstream event of CBFB loss. Immunohistochemistry shows that p73 loss is coupled with higher proliferation in xenografts. Moreover, TAp73 loss-of-expression is a frequent event in human breast cancer tumors and cell lines. Together, our results significantly advance our understanding of the tumor suppressive functions of CBFB and reveal a mechanism underlying the communication between the two tumor suppressors CBFB and p53.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS genetics, 2021 (prima pubblicazione 2021-05-04).
Identificativi: PMID 33945523 · PMCID PMC8121313 · DOI 10.1371/journal.pgen.1009553.
Descrittori MeSH principali: Gene Expression Regulation, Neoplastic.
Pagina: https://europepmc.org/article/MED/33945523 — https://doi.org/10.1371/journal.pgen.1009553. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-04T13:11:34.452Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.